Issues of the management of geriatric patients with valvular heart disease

Abstract

The present article describes a clinical case as an example of compiled treatment of a geriatric comorbid patient with aortic stenosis. The case mentioned in this article enhances and underlines the meaning of multidisciplinary approach in the treatment of such patients according to the contemporary and actual standpoints of geriatrics. Elderly patients are often reported to have comorbidities including valvular heart diseases which might be regarded as one of the most significant reasons for functional activity decrease and lower quality of life of an elderly patient. Meanwhile, it is necessary to admit that functional resources of some patients are very high. It must be taken into consideration when choosing the disease management.

Keywords

elderly patient / aortic stenosis / comprehensive geriatric assessment / quality of life

References

[1] d’Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37(47):3515–3522. DOI: 10.1093/eurheartj/ehw229

[2] d’Arcy J.L., Coffey S., Loudon M.A. et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study // Eur. Heart J. 2016. Vol. 37, No. 47. P. 3515–3522. DOI: 10.1093/eurheartj/ehw229

[3] Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the manegment of valvular heart disease. Eur Heart J. 2017;38(36):2739–2786. DOI: 10.1093/eurheartj/ehx391

[4] Baumgartner H., Falk V., Bax J.J. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease // Eur. Heart J. 2017. Vol. 38, No. 36. P. 2739–2786. DOI: 10.1093/eurheartj/ehx391

[5] d’Arcy JL, Prendengarst BD, Chambers JB, et al. Valvular heart disease: the next cardiac epidemic. Heart. 2011;97(2):91–93. DOI: 10.1136/hrt.2010.205096

[6] d’Arcy J.L., Prendengarst B.D., Chambers J.B. et al. Valvular heart disease: the next cardiac epidemic // Heart. 2011. Vol. 97, No. 2. P. 91–93. DOI: 10.1136/hrt.2010.205096

[7] Vahanian A, Lung B, Himbert D, Nataf P. Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies. Int J Cardiovasc Imaging. 2011;27(8):1115–1122. DOI: 10.1007/s10554-011-9804-7

[8] Vahanian A., Lung B., Himbert D., Nataf P. Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies // Int. J. Cardiovasc. Imaging. 2011. Vol. 27, No. 8. P. 1115–1122. DOI: 10.1007/s10554-011-9804-7

[9] Siontis GC, Praz F, Pilgrim TD, et al. Transcatheter aortic valve implantation vs. surgical aorticvalve replacement for treatment of severe aortic stenosis: a meta-analysis ofrandomized trials. Eur Heart J. 2016;37(47):3503–3512. DOI: 10.1093/eurheartj/ehw225

[10] Siontis G.C., Praz F., Pilgrim T.D. et al. Transcatheter aortic valve implantation vs. surgical aorticvalve replacement for treatment of severe aortic stenosis: a meta-analysis ofrandomized trials // Eur. Heart J. 2016. Vol. 37, No. 47. P. 3503–3512. DOI: 10.1093/eurheartj/ehw225

[11] Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical ortranscatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–1331. DOI: 10.1056/NEJMoa1700456

[12] Reardon M.J., Van Mieghem N.M., Popma J.J. et al. Surgical ortranscatheter aortic-valve replacement in intermediate-risk patients // N. Engl. J. Med. 2017. Vol. 376, No. 14. P. 1321–1331. DOI: 10.1056/NEJMoa1700456

[13] Ministerstvo zdravookhraneniya RF. Klinicheskie rekomendatsii. Perioperatsionnoe vedenie patsientov pozhilogo i starcheskogo vozrasta. 2018. 70 p. Available from: https://rgnkc.ru/images/pdf_documets/Pereoperatsionnoe_vedenie.pdf. Accessed: 19.09.2022. (In Russ.)

[14] Министерство здравоохранения РФ. Клинические рекомендации. Периоперационное ведение пациентов пожилого и старческого возраста. 2018. 70 с. Режим доступа: https://rgnkc.ru/images/pdf_documets/Pereoperatsionnoe_vedenie.pdf. Дата обращения: 19.09.2022.

[15] Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438–2488. DOI: 10.1016/j.jacc.2014.02.537

[16] Nishimura R.A., Otto C.M., Bonow R.O. et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines // J. Am. Coll. Cardiol. 2014. Vol. 63, No. 22. Р. 2438–2488. DOI: 10.1016/j.jacc.2014.02.537

[17] Ministerstvo zdravookhraneniya RF. Klinicheskie rekomendatsii. Nedostatochnost’ pitaniya (mal’nutritsiya) u patsientov pozhilogo i starcheskogo vozrasta. 2020. Available from: https://legalacts.ru/doc/klinicheskie-rekomendatsii-nedostatochnost-pitanija-malnutritsija-u-patsientov-pozhilogo-i/. Accessed: 19.09.2022. (In Russ.)

[18] Министерство здравоохранения РФ. Клинические рекомендации. Недостаточность питания (мальнутриция) у пациентов пожилого и старческого возраста. 2020. Режим доступа: https://legalacts.ru/doc/klinicheskie-rekomendatsii-nedostatochnost-pitanija-malnutritsija-u-patsientov-pozhilogo-i/. Дата обращения: 19.09.2022.

[19] Kotovskaya YuV, Tkacheva ON, Sergienko IV. Lipid-lowering therapy for primary cardiovascular prevention in older adults. Consensus Statement of the Russian Association of Gerontologists and Geriatricians, National Society on Atherosclerosis, Russian Society of Cardiology, Association of Clinical Pharmacologists. Kardiologiia. 2020;60(6):119–132. (In Russ.). DOI: 10.18087/cardio.2020.6.n1037

[20] Котовская Ю.В., Ткачева О.Н., Сергиенко И.В. Липидснижающая терапия для первичной профилактики у пациентов 75 лет и старше. Консенсус экспертов Российской ассоциации геронтологов и гериатров, Национального общества по изучению атеросклероза, Российского кардиологического общества, Ассоциации клинических фармакологов // Кардиология. 2020. Т. 60, № 6. С. 119–132. DOI: 10.18087/cardio.2020.6.n1037

[21] Tkacheva ON, Vorobyeva NM, Kotovskaya YuV, et al. Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the Russian Association of Gerontologists and Geriatricians and the National Society of Preventive Cardiology. Cardiovascular Therapy and Prevention. 2021;20(3):135–184. (In Russ.). DOI: 10.15829/1728-8800-2021-2847

[22] Ткачева О.Н., Воробьева Н.М., Котовская Ю.В. и др. Антитромботическая терапия в пожилом и старческом возрасте: согласованное мнение экспертов Российской ассоциации геронтологов и гериатров и национального общества профилактической кардиологии // Кардиоваскулярная терапия и профилактика. 2021. Т. 20, № 3. С. 135–184. DOI: 10.15829/1728-8800-2021-2847

[23] Turusheva A, Frolova E, Bogdanova T. Impact of cognitive impairment on the prevalence and course of geriatric syndromes. Vrach. 2022;33(3):62–67. (In Russ.). DOI: 10.29296/25877305-2022-03-12

[24] Турушева А.В., Фролова Е.В., Богданова Т.А. Влияние когнитивных нарушений на распространенность и течение гериатрических синдромов // Врач. 2022. Т. 33, № 3. С. 62–67. DOI: 10.29296/25877305-2022-03-12

[25] Turusheva AV, Moiseeva IE. Malnutrition in the elderly and old age. Russian Family Doctor. 2018;23(1):5–15. (In Russ.). DOI: 10.17816/RFD201915-15

[26] Турушева А.В., Моисеева И.Е. Недостаточность питания в пожилом и старческом возрасте // Российский семейный врач. 2019. Т. 23, № 1. С. 5–15. DOI: 10.17816/RFD201915-15

[27] Brown AF, Mangione CM, Saliba D, et al. Guidelines for Improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–280. DOI: 10.1046/j.1532-5415.51.5s.1.x

[28] Brown A.F., Mangione C.M., Saliba D. et al. Guidelines for Improving the care of the older person with diabetes mellitus // J. Am. Geriatr. Soc. 2003. Vol. 51, No. 5 Suppl Guidelines. P. S265–280. DOI: 10.1046/j.1532-5415.51.5s.1.x

[29] Abraria С, Duckworth W, McCarren М, et al. Desing of cooperative study on glycemic control and complication in diabetes mellitus type 2 veterans affairs diabetes trial. J Diabetes Complications. 2003;17(6):314–322. DOI: 10.1016/s1056-8727 (02)00277-5

[30] Abraria С., Duckworth W., McCarren М. et al. Desing of cooperative study on glycemic control and complication in diabetes mellitus type 2 veterans affairs diabetes trial // J. Diabetes Complications. 2003. Vol. 17, No. 6. P. 314–322. DOI: 10.1016/s1056-8727 (02)00277-5

[31] Gallo JJ, Hwang S, Joo JH, et al. Multimorbidity, depression, and mortality in primary care: randomized clinical trial of an evidence-based depression care management program on mortality risk. J Gen Intern Med. 2016;31(4):380–386. DOI: 10.1007/s11606-015-3524-у

[32] Gallo J.J., Hwang S., Joo J.H. et al. Multimorbidity, depression, and mortality in primary care: randomized clinical trial of an evidence-based depression care management program on mortality risk // J. Gen. Intern. Med. 2016. Vol. 31, No. 4. P. 380–386. DOI: 10.1007/s11606-015-3524-у

[33] Surtees PG, Wainwright NWJ, Luben RN, et al. Depression and ischemic heart disease mortality: evidence from the EPICNorfolk United Kingdom Prospective Cohort Study. Am J Psychiatry. 2008;165(4):515–523. DOI: 10.1176/appi.ajp.2007.07061018

[34] Surtees P.G., Wainwright N.W.J., Luben R.N. et al. Depression and ischemic heart disease mortality: evidence from the EPICNorfolk United Kingdom Prospective Cohort Study // Am. J. Psychiatry. 2008. Vol. 165, No. 4. P. 515–523. DOI: 10.1176/appi.ajp.2007.07061018

RIGHTS & PERMISSIONS

Frolova E.V., Pankratova O.Y.